| Table 1: P values for multiple assessments of visible injury, yield, and whole grain for preemergence (PRE) and postemergence (POST) applications of saflufenacil. |
| | Experiment | Source of variation | Pr > F for analyzed parameters | | Visible injurya | Yield | Whole grain | | 1st | 2nd | 3rd | 4th |
| | PRE | Year (Y) | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | | Block (year) | <0.0001 | 0.040 | 0.072 | 0.979 | 0.701 | 0.771 | | Clomazone (C) | <0.0001 | <0.0001 | <0.0001 | 0.007 | 0.025 | 0.772 | | C*Y | <0.0001 | <0.0001 | <0.0001 | 0.007 | 0.641 | 0.0008 | | Saflufenacil (S) | 0.001 | <0.0001 | 0.128 | <0.0001 | 0.151 | 0.699 | | S*Y | 0.198 | 0.0003 | 0.015 | <0.0001 | 0.912 | 0.669 | | C*S | 0.495 | 0.163 | 0.458 | 0.109 | 0.450 | 0.971 | | C*S*Y | 0.047 | 0.020 | 0.764 | 0.109 | 0.809 | 0.614 |
| | POST | Year (Y) | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | | Block (year) | 0.016 | 0.193 | <0.0001 | 0.0135 | 0.020 | 0.0003 | | Clomazone (C) | <0.0001 | <0.0001 | 0.589 | 0.329 | 0.012 | 0.029 | | C*Y | 0.017 | 0.026 | 0.589 | 0.329 | 0.050 | 0.029 | | Saflufenacil (S) | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.272 | 0.7475 | | S*Y | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.659 | 0.804 | | C*S | <0.0001 | <0.0001 | 0.0008 | 0.0037 | 0.634 | 0.274 | | C*S*Y | <0.0001 | <0.0001 | 0.0008 | 0.0037 | 0.973 | 0.956 |
|
|
aRepresents the 1st, 2nd, 3rd, and 4th assessment evaluations for visible injury.
|